I agree. Dr. Rogers came out of the blue. First
Post# of 9122
(Total Views: 510)
Posted On: 07/10/2020 10:10:01 PM
Re: Machiavelli20 #6682
I agree.
Dr. Rogers came out of the blue. First thing I did upon Rogers entrance was google him,immediately seeing the Biomotiv connection,the company he apparently still works for -and I was a bit surprised because larger companies usually dont like to loan out their leaders-especially to small companies.
Non-compete clauses usually prevent the loaning of a bigger companies leaders. So Dr. Rogers may have initially thought he had the imprimatur (approval) of Biomotiv,only to find second thoughts by Biomotiv later. Or speculations already posted on this board could be the reason-I have no idea.
But NNLX already has NDA's with at least 2 companies,which don't depend on Dr. Rogers,and a unique inexpensive test without false results which can be done on site (home or office) without multiple days delay to mail to a lab for processing.
So the technology stands on its own two feet.
https://www.biomotiv.com/operations-team
Posted On: 06/03/2020 5:00:23 PM
Posted By: Machiavelli20
Re: rayludwiczak #6382
The key is that the prior technologies were either ones that had a reasonably narrow competitive edge over ones that major companies and suppliers had already locked in and were receiving remittances of some sort (kickbacks) or was in a niche that those committed to PCR and other type technologies had a close enough edge that they could ignore the development.
This diagnostic technology is so accurate and comprehensive across a number of critical categories that there is nothing competitive --except when the others cheat and have to be sued for patent infringement. My mantra is that I trust no one. Virtually everyone can be bought when the $$ are enough. So, given the technology as Faro and James Rogers (long term Battelle) describes, there is no equivalent in a critical global emergency. NNLX possesses the tech and has filed for the provisional patent and EUA for it to gain legal protection, there is an incredible need for this specific patented technology in the US, Europe, China (steals), etc. so the reality is that one way or another through a large scale marketing partner or a longer term law suit NNLX "wins". Although experience keeps us from being insane, $.08 or .15, or .50 simply does not make sense. Although we live in an insane nonsensical world. So unless you have a need for $500-$1500 gain you would be nuts to bail. But go ahead.
Read More: https://investorshangout.com/Nanologix-Inc-NN...z6RqcCGq5V
Posted On: 05/18/2020 12:35:54 PM
Posted By: Sierra
Re: ronclaw47 #6162
NanoLogix Sub 1-Hour Covid-19 Detection Test Now
Patent-Pending
Patent Application Filed Under New COVID-19 Prioritized Examination Pilot Program
NanoLogix is pleased to announce the filing of a patent application for use in the rapid testing for the Covid-19 virus. The application was filed under a new program instituted May 14th by the US Patent and Trademark Office. Now that Patent-Pending status has been obtained, we can reveal aspects of the technology that we were unable to mention in a prior update.
This Rapid Viral Assay is a modified ELISA technology that is not the same as our N-Assay modified ELISA.
While the initial focus for development was for the COVID-19 virus, it became obvious that the technology is not limited to one virus, but can be configured for many different viruses, such as HIV, HPV, Hepatitis, MERS, SARS-1 and others. As per the patent filing, the description is "Without Limitation".
An additional aspect of the test is that for the Home-Test configuration, we anticipate the potential of 30-minute results using a nasopharyngeal swab sample or saliva.
Jonathan Faro, MD, PhD., our Chief Medical Officer stated "We are extremely excited over this technology development, as it is a novel approach in diagnostics that provides a solution to the inherent problems with false positives and false negatives present in those tests currently being used in the war against COVID-19."
The US Patent Office program under which the filing was done can be accessed through the following link:
https://www.federalregister.gov/documents/202...program
Read More: https://investorshangout.com/post/view?id=577...z6RqchM5k6
Dr. Rogers came out of the blue. First thing I did upon Rogers entrance was google him,immediately seeing the Biomotiv connection,the company he apparently still works for -and I was a bit surprised because larger companies usually dont like to loan out their leaders-especially to small companies.
Non-compete clauses usually prevent the loaning of a bigger companies leaders. So Dr. Rogers may have initially thought he had the imprimatur (approval) of Biomotiv,only to find second thoughts by Biomotiv later. Or speculations already posted on this board could be the reason-I have no idea.
But NNLX already has NDA's with at least 2 companies,which don't depend on Dr. Rogers,and a unique inexpensive test without false results which can be done on site (home or office) without multiple days delay to mail to a lab for processing.
So the technology stands on its own two feet.
https://www.biomotiv.com/operations-team
Posted On: 06/03/2020 5:00:23 PM
Posted By: Machiavelli20
Re: rayludwiczak #6382
The key is that the prior technologies were either ones that had a reasonably narrow competitive edge over ones that major companies and suppliers had already locked in and were receiving remittances of some sort (kickbacks) or was in a niche that those committed to PCR and other type technologies had a close enough edge that they could ignore the development.
This diagnostic technology is so accurate and comprehensive across a number of critical categories that there is nothing competitive --except when the others cheat and have to be sued for patent infringement. My mantra is that I trust no one. Virtually everyone can be bought when the $$ are enough. So, given the technology as Faro and James Rogers (long term Battelle) describes, there is no equivalent in a critical global emergency. NNLX possesses the tech and has filed for the provisional patent and EUA for it to gain legal protection, there is an incredible need for this specific patented technology in the US, Europe, China (steals), etc. so the reality is that one way or another through a large scale marketing partner or a longer term law suit NNLX "wins". Although experience keeps us from being insane, $.08 or .15, or .50 simply does not make sense. Although we live in an insane nonsensical world. So unless you have a need for $500-$1500 gain you would be nuts to bail. But go ahead.
Read More: https://investorshangout.com/Nanologix-Inc-NN...z6RqcCGq5V
Posted On: 05/18/2020 12:35:54 PM
Posted By: Sierra
Re: ronclaw47 #6162
NanoLogix Sub 1-Hour Covid-19 Detection Test Now
Patent-Pending
Patent Application Filed Under New COVID-19 Prioritized Examination Pilot Program
NanoLogix is pleased to announce the filing of a patent application for use in the rapid testing for the Covid-19 virus. The application was filed under a new program instituted May 14th by the US Patent and Trademark Office. Now that Patent-Pending status has been obtained, we can reveal aspects of the technology that we were unable to mention in a prior update.
This Rapid Viral Assay is a modified ELISA technology that is not the same as our N-Assay modified ELISA.
While the initial focus for development was for the COVID-19 virus, it became obvious that the technology is not limited to one virus, but can be configured for many different viruses, such as HIV, HPV, Hepatitis, MERS, SARS-1 and others. As per the patent filing, the description is "Without Limitation".
An additional aspect of the test is that for the Home-Test configuration, we anticipate the potential of 30-minute results using a nasopharyngeal swab sample or saliva.
Jonathan Faro, MD, PhD., our Chief Medical Officer stated "We are extremely excited over this technology development, as it is a novel approach in diagnostics that provides a solution to the inherent problems with false positives and false negatives present in those tests currently being used in the war against COVID-19."
The US Patent Office program under which the filing was done can be accessed through the following link:
https://www.federalregister.gov/documents/202...program
Read More: https://investorshangout.com/post/view?id=577...z6RqchM5k6
(5)
(1)Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼